A Phase 2 Study to Evaluate the Efficacy and Safety of Belzutifan (MK-6482, Formerly PT2977) Monotherapy in Participants With Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Advanced Solid Tumors With HIF-2α Related Genetic Alterations

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT04924075

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-25T22:29:03.773393+00:00

Published At

2026-04-23T00:00:00+00:00

Record Updated At

2026-04-23

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Pheochromocytoma/Paraganglioma", "Pancreatic Neuroendocrine Tumor", "Von Hippel-Lindau Disease", "Advanced Gastrointestinal Stromal Tumor", "HIF-2\u03b1 Mutated Cancers"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2026-04-23"

protocolSection.identificationModule.nctId

"NCT04924075"

protocolSection.identificationModule.officialTitle

"A Phase 2 Study to Evaluate the Efficacy and Safety of Belzutifan (MK-6482, Formerly PT2977) Monotherapy in Participants With Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Advanced Solid Tumors With HIF-2\u03b1 Related Genetic Alterations"

protocolSection.statusModule.overallStatus

"RECRUITING"

protocolSection.designModule.phases

["PHASE2"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Pheochromocytoma/Paraganglioma (protocolSection.conditionsModule.conditions)
• Pancreatic Neuroendocrine Tumor (protocolSection.conditionsModule.conditions)
• Von Hippel-Lindau Disease (protocolSection.conditionsModule.conditions)
• Advanced Gastrointestinal Stromal Tumor (protocolSection.conditionsModule.conditions)
• HIF-2α Mutated Cancers (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.